TR199501082A2 - Pharmaceutical formulations. - Google Patents

Pharmaceutical formulations.

Info

Publication number: TR199501082A2
Authority: TR; Turkey
Prior art keywords: pharmaceutical formulations; formulations; pharmaceutical
Prior art date: 1994-09-03

Application number

TR95/01082A

Other languages

Turkish (tr)

Inventor

Patrick John Crowley

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-09-03

Filing date

1995-08-31

Publication date

1996-06-21

1994-09-03 Priority claimed from GB9417953A external-priority patent/GB9417953D0/en

1995-02-24 Priority claimed from GBGB9503752.9A external-priority patent/GB9503752D0/en

1995-08-31 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

1996-06-21 Publication of TR199501082A2 publication Critical patent/TR199501082A2/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

TR95/01082A 1994-09-03 1995-08-31 Pharmaceutical formulations. TR199501082A2 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GB9417953A GB9417953D0 (en)	1994-09-03	1994-09-03	Pharmaceutical formulations
GBGB9503752.9A GB9503752D0 (en)	1995-02-24	1995-02-24	Pharmaceutical formulations
US46044195A	1995-06-02	1995-06-02

Publications (1)

Publication Number	Publication Date
TR199501082A2 true TR199501082A2 (en)	1996-06-21

Family

ID=27267365

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TR95/01082A TR199501082A2 (en)	1994-09-03	1995-08-31	Pharmaceutical formulations.

Country Status (8)

Country	Link
EP (1)	EP0782443A1 (en)
JP (1)	JPH10505595A (en)
AU (1)	AU3471995A (en)
DZ (1)	DZ1926A1 (en)
IL (1)	IL115125A0 (en)
MA (1)	MA23663A1 (en)
TR (1)	TR199501082A2 (en)
WO (1)	WO1996007408A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1093812A3 (en)	1995-09-07	2001-06-06	SmithKline Beecham Corporation	Amoxycillin and clavulanate containing pharmaceutical formulation
AU728526B2 (en) *	1997-02-14	2001-01-11	Smithkline Beecham Corporation	Pharmaceutical formulations comprising amoxocyllin and clavulanate
DE69922202T2 (en) *	1998-07-06	2005-12-01	Nanobac Oy	METHOD OF REMOVING NANOBAKTERIA
US6706290B1 (en)	1998-07-06	2004-03-16	Olvai E. Kajander	Methods for eradication of nanobacteria
US6294199B1 (en)	1999-04-13	2001-09-25	Beecham Pharmaceuticals (Pte) Limited	Method of treating a bacterial infection comprising administering amoxycillin
US6878386B1 (en)	1999-04-13	2005-04-12	Beecham Pharmaceuticals (Pte) Limited	Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US7250176B1 (en)	1999-04-13	2007-07-31	Beecham Pharmaceuticals (Pte) Limited	Method of treating a bacterial infection
US6756057B2 (en)	2000-10-12	2004-06-29	Beecham Pharmaceuticals (Pte) Limited	Amoxicillin and potassium clavulanate dosage form
WO2002030392A2 (en)	2000-10-12	2002-04-18	Beecham Pharmaceuticals (Pte) Limited	Formulation containing amoxicillin
US8614315B2 (en) *	2009-12-25	2013-12-24	Mahmut Bilgic	Cefdinir and cefixime formulations and uses thereof
TR201000688A2 (en)	2010-01-29	2011-08-22	B�Lg�� Mahmut	Effervescent formulations containing cefaclor and clavulanic acid as active ingredient.
WO2011152806A1 (en) *	2010-06-03	2011-12-08	Mahmut Bilgic	Production method for the effervescent formulation comprising cephalosporin and potassium clavulanate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2861607D1 (en) *	1977-11-26	1982-03-11	Beecham Group Plc	Derivatives of clavulanic acid and pharmaceutical compositions containing them
NZ198241A (en) *	1980-09-27	1983-12-16	Beecham Group Ltd	Tablet containing amoxycillin and potassium clavulanate
JPH08505868A (en) *	1993-01-22	1996-06-25	スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー	Pharmaceutical formulations consisting of clavulanic acid alone or clavulanic acid mixed with other beta-lactam antibiotics

1995
- 1995-08-02 DZ DZ950107A patent/DZ1926A1/en active
- 1995-08-21 EP EP95931176A patent/EP0782443A1/en not_active Withdrawn
- 1995-08-21 WO PCT/EP1995/003322 patent/WO1996007408A1/en not_active Application Discontinuation
- 1995-08-21 JP JP8509160A patent/JPH10505595A/en not_active Ceased
- 1995-08-21 AU AU34719/95A patent/AU3471995A/en not_active Abandoned
- 1995-08-31 TR TR95/01082A patent/TR199501082A2/en unknown
- 1995-09-01 IL IL11512595A patent/IL115125A0/en unknown
- 1995-09-01 MA MA24005A patent/MA23663A1/en unknown

Also Published As

Publication number	Publication date
JPH10505595A (en)	1998-06-02
EP0782443A1 (en)	1997-07-09
MA23663A1 (en)	1996-04-01
DZ1926A1 (en)	2002-02-17
AU3471995A (en)	1996-03-27
IL115125A0 (en)	1995-12-31
WO1996007408A1 (en)	1996-03-14

Publication	Publication Date	Title
BR9610153A (en)	1999-01-05	Pharmaceutical formulations
BR9611626A (en)	1999-06-01	Pharmaceutical formulations
TR199901077A3 (en)	1999-12-21	Pharmaceutical formulations.
DE69530325D1 (en)	2003-05-15	AEROSOL DRUG FORMULATIONS
FI971279A (en)	1997-03-26	Drug
DZ2026A1 (en)	2002-07-21	Vaccinating compositions.
DZ2055A1 (en)	2002-10-20	Vaccinating compositions.
ID24654A (en)	2000-07-27	OMEPRAZOLA PHARMACEUTICAL FORMULATION
NO954486D0 (en)	1995-11-08	Pharmaceutical formulation basis
DZ1835A1 (en)	2002-02-17	New formulations.
ID18352A (en)	1998-04-02	PHARMACEUTICAL COMPOSITIONS
TR199501082A2 (en)	1996-06-21	Pharmaceutical formulations.
ID16781A (en)	1997-11-13	PHARMACEUTICAL FORMULATIONS
BR9507768A (en)	1997-09-02	Pharmaceutical composition
ITMI941169A0 (en)	1994-06-06	PHARMACEUTICAL FORMULATIONS
PT941100E (en)	2003-10-31	PHARMACEUTICAL COMPOSITIONS
ITMI942166A0 (en)	1994-10-21	PHARMACEUTICAL COMPOSITIONS MIORELAXANTS
FI951155A0 (en)	1995-03-13	Pharmaceutical preparation
TR199601018A1 (en)	1997-07-21	Pharmaceutical compounds.
ITMI962628A0 (en)	1996-12-16	PHARMACEUTICAL COMPOSITION
FI962738A0 (en)	1996-07-03	Pharmaceutical compositions
FI934317A0 (en)	1993-10-01	PHARMACEUTICAL SAMMANSAETTNINGAR, VILKA INNEHAOLLER EJ-JONISKA YTAKTIVA AEMNEN
TR199500776A2 (en)	1996-06-21	Pharmaceutical compositions.
SE9404467D0 (en)	1994-12-22	Drug formulations
SE9502453D0 (en)	1995-07-06	Drug formulations